Nasolabial Fold Wrinkles
8
1
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
CelluJuve® for the Treatment of Moderate to Severe NLFs
Randomized Masked Trial of Injectable Cross-Linked Hyaluronic Acid for Moderate-to-Severe Nasolabial Folds
BC-101 in Treatment of Nasolabial Fold Wrinkles
Evaluation of Facial HA Dermal Fillers in Real-Life Conditions
Prospective, Multicentre, Randomized, Blind, Parallel-controlled Clinical Trial Evaluating the Efficacy and Safety of Recombinant Collagen Gel for Correcting Moderate to Severe Nasolabial Wrinkles
Polymeric Microspheres vs Sculptra® in the Treatment of Moderate to Severe Nasolabial Folds
DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term Follow-up
DL6049 vs CosmoPlast in the Treatment of Nasolabial Fold Wrinkles